High sensitivity automated multiplexed immunoassays using photonic crystal enhanced fluorescence microfluidic system

Biosensors and Bioelectronics

Volumn 73, Issue , 2015, Pages 32-40

  Tan, Yafang ^a   Tang, Tiantian ^a   Xu, Haisheng ^a   Zhu, Chenqi ^a   Cunningham, Brian T ^a  

^a University of Illinois at Urbana Champaign   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; AUTOMATION; DIAGNOSIS; FLUIDIC DEVICES; FLUORESCENCE; MICROFLUIDICS; MULTIPLEXING; PHOTONIC CRYSTALS; PROJECTILES; QUANTUM OPTICS;

COEFFICIENTS OF VARIABILITIES; ENHANCED FLUORESCENCE; EXCITATION WAVELENGTH; FLUORESCENCE SIGNALS; LIMITS OF DETECTION; MICRO FLUIDIC SYSTEM; MICRO-FLUIDIC DEVICES; TUMOR NECROSIS FACTORS;

COMPUTER CONTROL SYSTEMS;

INTERLEUKIN 3; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; IL3 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ARTICLE; AUTOMATION; BIOASSAY; CONTROLLED STUDY; EQUIPMENT DESIGN; FLUORESCENCE ANALYSIS; IMMUNOASSAY; LIMIT OF DETECTION; MATERIALS HANDLING; MICROARRAY ANALYSIS; MICROFLUIDIC ANALYSIS; PHOTONIC CRYSTAL ENHANCED FLUORESCENCE; REPRODUCIBILITY; SENSITIVITY ANALYSIS; DEVICES; FLUORESCENCE; GENETIC PROCEDURES; HUMAN; LAB ON A CHIP; POINT OF CARE SYSTEM; PROCEDURES;

BIOMARKERS; BIOSENSING TECHNIQUES; EQUIPMENT DESIGN; FLUORESCENCE; HUMANS; IMMUNOASSAY; INTERLEUKIN-3; LAB-ON-A-CHIP DEVICES; LIMIT OF DETECTION; MICROFLUIDIC ANALYTICAL TECHNIQUES; POINT-OF-CARE SYSTEMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84930633575     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2015.05.041     Document Type: Article

References (42)

1. Au A.K., Lee W., Folch A. Mail-order microfluidics: evaluation of stereolithography for the production of microfluidic devices. Lab Chip 2014, 14:1294-1301.
2. Bettegowda C., Sausen M., Leary R.J., Kinde I., Wang Y., Agrawal N., et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl. Med. 2014, 6:224ra24.
3. Block I.D., Mathias P.C., Ganesh N., Jones S.I., Dorvel B.R., Chaudhery V., et al. A detection instrument for enhanced-fluorescence and label-free imaging on photonic crystal surfaces. Opt. Express 2009, 17:13222-13235.
4. Borras T.G.L., Tietz J. Generic approach for the generation of stable humanized single-chain Fv fragments from rabbit monoclonal antibodies. J. Biol. Chem. 2010, 285:12.
5. Chaudhery V., Lu M., Huang C., George S., Cunningham B. Photobleaching on photonic crystal enhanced fluorescence surfaces. J. Fluoresc. 2011, 21:707-714. 2011/03/01.
6. Chaudhery V., Lu M., Huang C.-S., Polans J., Tan R., Zangar R.C. A line-scanning detection instrument for photonic crystal enhanced fluorescence. Opt. Lett. 2012, 37:2565-2567.
7. Choudhury I.A., Shirley S. Laser cutting of polymeric materials: an experimental investigation. Opt. Laser Technol. 2010, 42:503-508. 4//.
8. Dawson S.-J., Tsui D.W.Y., Murtaza M., Biggs H., Rueda O.M., Chin S.-F., et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 2013, 368:1199-1209.
9. Debnath M. Molecular Diagnostics: Promises and Possibilities, 2010, 503-513. Springer Science+Business Media.
10. Diamandis E.P., Borgono C.A., Scorilas A., Yousef G.M., Harbeck N., Dorn J., et al. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis. Tumor Biol. 2003, 24:299-309.
11. Diamandis E.P., Scorilas A., Fracchioli S., van Gramberen M., de Bruijn H., Henrik A., et al. Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J. Clin. Oncol. 2003, 21:1035-1043. 15.
12. Dorvel B., Reddy B., Block I., Mathias P., Clare S.E., Cunningham B., et al. Vapor-phase deposition of monofunctional alkoxysilanes for sub-nanometer-level biointerfacing on silicon oxide surfaces. Adv. Funct. Mater. 2009, 20:87-95.
13. 2 laser cutting process parameters on edge quality and operating cost of AISI316L. Opt. Laser Technol. 2012, 44:1068-1082. 6//.
14. Fan R., Vermesh O., Srivastava A., Yen B.K.H., Qin L.D., Ahmad H., et al. Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nat. Biotechnol. 2008, 26:1373-1378.
15. Ganesh N., Zhang W., Mathias P.C., Chow E., Soares J.A.N.T., Malyarchuk V., et al. Enhanced fluorescence emission from quantum dots on a photonic crystal surface. Nat. Nano 2007, 2:515-520. 08//print.
16. George S., Chaudhery V., Lu M., Takagi M., Amro N., Pokhriyal A., et al. Sensitive detection of protein and miRNA cancer biomarkers using silicon-based photonic crystals and a resonance coupling laser scanning platform. Lab Chip 2013, 13:4053-4064.
17. Gonzalez R.M., Daly D.S., Tan R., Marks J.R., Zangar R.C. Plasma biomarker profiles differ depending on breast cancer subtype but RANTES in consistently increased. Cancer Epidemiol. Biomark. Prev. 2015, 20:1543-1551.
18. Huang C.-S., George S., Lu M., Chaudhery V., Tan R., Zangar R.C., et al. Application of photonic crystal enhanced fluorescence to cancer biomarker microarrays. Anal. Chem. 2011, 83:1425-1430. 2011/02/15.
19. Jain K.K. The Handbook of Biomarkers: Springer Science+Business Media 2010, Humana Press.
20. Jeffrey S.S. Cancer biomarker profiling with microRNAs. Nat. Biotechnol. 2008, 26:400-401. 04//print.
21. Khoo S.K., Petillo D., Kang U.J., Resau J.H., Berryhill B., Linder J., et al. Plasma-based circulating microRNA biomarkers for Parkinson's disease. J. Parkinson's Dis. 2012, 2:321-331. 01/01/.
22. Luo L.Y., Katsaros D., Scorilas A., Fracchioli S., Bellino R., van Gramberen M., et al. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Cancer Res. 2003, 63:807-811.
23. Maurya P., Meleady P., Dowling P., Clynes M. Proteomic approaches for serum biomarker discovery in cancer. Anticancer Res. 2007, 27:1247-1255.
24. Melchels F.P.W., Feijen J., Grijpma D.W. A review on stereolithography and its applications in biomedical engineering. Biomaterials 2010, 31:6121-6130. 8//.
25. Nam M.J., Madoz-Gurpide J., Wang H., Lescure P., Schmalbach C.E., Zhao R., et al. Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics 2003, 3:2108-2115.
26. Neagu M., Constantin C., Tanase C., Boda D. Patented biomarker panels in early detection of cancer. Recent Pat. Biomark. 2011, 1:10-24.
27. Newman A.M., Bratman S.V., To J., Wynne J.F., Eclov N.C.W., Modlin L.A. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat. Med. 2014, 20(5):548-554.
28. Nie J., Liang Y., Zhang Y., Le S., Li D., Zhang S. One-step patterning of hollow microstructures in paper by laser cutting to create microfluidic analytical devices. Analyst 2013, 138:671-676.
29. Patz E.F., Campa M.J., Gottlin E.B., Kusmartseva I., Guan X.R., Herndon J.E. Panel of serum biomarkers for the diagnosis of lung cancer. J. Clin. Oncol. 2007, 25:5578-5583.
30. Pokhriyal A., Lu M., Chaudhery V., Huang C.-S., Schulz S., Cunningham B.T. Photonic crystal enhanced fluorescence using a quartz substrate to reduce limits of detection. Opt. Express 2010, 18:24793-24808. 2010/11/22.
31. Robinson W.H., DiGennaro C., Hueber W., Haab B.B., Kamachi M., Dean E.J., et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 2002, 8:295-301.
32. Sita-Lumsden A., Dart D.A., Waxman J., Bevan C.L. Circulating microRNAs as potential new biomarkers for prostate cancer. Br. J. Cancer 2013, 108:1925-1930. 05/28/print.
33. Tannapfel A., Anhalt K., Hausermann P., Sommerer F., Benicke M., Uhlmann D., et al. Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J. Pathol. 2003, 201:238-249.
34. Vasan R.S. Biomarkers of cardiovascular disease-molecular basis and practical considerations. Circulation 2006, 113:2335-2362.
35. Wang T.J., Gona P., Larson M.G., Tofler G.H., Levy D., Newton-Cheh C., et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N. Engl. J. Med. 2006, 355:2631-2639.
36. Ward D.G., Suggett N., Cheng Y., Wei W., Johnson H., Billingham L.J., et al. Identification of serum biomarkers for colon cancer by proteomic analysis. Br. J. Cancer 2006, 94:1898-1905.
37. Wilhelm E., Neumann C., Duttenhofer T., Pires L., Rapp B.E. Connecting microfluidic chips using a chemically inert, reversible, multichannel chip-to-world-interface. Lab Chip 2013, 13:4343-4351.
38. Wong J., Sibani S., Lokko N.N., LaBaer J., Anderson K.S. Rapid detection of antibodies in sera using multiplexed self-assembling bead arrays. J. Immunol. Methods 2009, 350:171-182.
39. Zangar R.C., Varnum S.M., Bollinger N. Studying cellular processes and detecting disease with protein microarrays. Drug Metab. Rev. 2005, 37:473-487.
40. Zhang A.P., Qu X., Soman P., Hribar K.C., Lee J.W., Chen S., et al. Rapid fabrication of complex 3D extracellular microenvironments by dynamic optical projection stereolithography. Adv. Mater. 2012, 24:4266-4270.
41. Zhang Z., Bast R.C., Yu Y.H., Li J.N., Sokoll L.J., Rai A.J., et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004, 64:5882-5890.
42. Zhu H., Klemic J.F., Chang S., Bertone P., Casamayor A., Klemic K.G., et al. Analysis of yeast protein kinases using protein chips. Nat. Genet. 2000, 26:283-290.